BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11858476)

  • 1. The role of alpha(v)beta3 integrins in vascular healing.
    Sajid M; Stouffer GA
    Thromb Haemost; 2002 Feb; 87(2):187-93. PubMed ID: 11858476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta3 integrins are upregulated after vascular injury and modulate thrombospondin- and thrombin-induced proliferation of cultured smooth muscle cells.
    Stouffer GA; Hu Z; Sajid M; Li H; Jin G; Nakada MT; Hanson SR; Runge MS
    Circulation; 1998 Mar; 97(9):907-15. PubMed ID: 9521340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple roles for platelet GPIIb/IIIa and alphavbeta3 integrins in tumor growth, angiogenesis, and metastasis.
    Trikha M; Zhou Z; Timar J; Raso E; Kennel M; Emmell E; Nakada MT
    Cancer Res; 2002 May; 62(10):2824-33. PubMed ID: 12019160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced intimal thickening following alpha(v)beta3 blockade is associated with smooth muscle cell apoptosis.
    van der Zee R; Murohara T; Passeri J; Kearney M; Cheresh DA; Isner JM
    Cell Adhes Commun; 1998; 6(5):371-9. PubMed ID: 10223353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of selective or combined inhibition of integrins alpha(IIb)beta(3) and alpha(v)beta(3) on thrombosis and neointima after oversized porcine coronary angioplasty.
    Chico TJ; Chamberlain J; Gunn J; Arnold N; Bullens SL; Gadek TR; Francis SE; Bunting S; Horton M; Shepherd L; Lipari MT; Quan C; Knolle J; Stilz HU; Peyman A; Crossman DC
    Circulation; 2001 Feb; 103(8):1135-41. PubMed ID: 11222478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrins alpha(v)beta3 and alpha(v)beta5 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramide.
    Erdreich-Epstein A; Shimada H; Groshen S; Liu M; Metelitsa LS; Kim KS; Stins MF; Seeger RC; Durden DL
    Cancer Res; 2000 Feb; 60(3):712-21. PubMed ID: 10676658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c7E3 Fab inhibits low shear flow modulated platelet adhesion to endothelium and surface-absorbed fibrinogen by blocking platelet GP IIb/IIIa as well as endothelial vitronectin receptor--results from patients with acute myocardial infarction and healthy controls.
    Reininger AJ; Agneskirchner J; Bode PA; Spannagl M; Wurzinger LJ
    Thromb Haemost; 2000 Feb; 83(2):217-23. PubMed ID: 10739376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine and oxidized low density lipoprotein enhanced platelet adhesion to endothelial cells under flow conditions: distinct mechanisms of thrombogenic modulation.
    Dardik R; Varon D; Tamarin I; Zivelin A; Salomon O; Shenkman B; Savion N
    Thromb Haemost; 2000 Feb; 83(2):338-44. PubMed ID: 10739396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitronectin receptor (alpha(v)beta3) mediates platelet adhesion to the luminal aspect of endothelial cells: implications for reperfusion in acute myocardial infarction.
    Gawaz M; Neumann FJ; Dickfeld T; Reininger A; Adelsberger H; Gebhardt A; Schömig A
    Circulation; 1997 Sep; 96(6):1809-18. PubMed ID: 9323066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet glycoprotein IIb/IIIa antagonists in percutaneous coronary interventions.
    Gambhir DS; Mukhopadhyay S
    Indian Heart J; 2000; 52(5):524-32. PubMed ID: 11256774
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of abciximab and tirofiban on vitronectin receptors in human endothelial and smooth muscle cells.
    Kintscher U; Kappert K; Schmidt G; Doerr G; Grill M; Wollert-Wulf B; Graefe M; Fleck E; Graf K
    Eur J Pharmacol; 2000 Feb; 390(1-2):75-87. PubMed ID: 10708709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist.
    Kumar CC; Malkowski M; Yin Z; Tanghetti E; Yaremko B; Nechuta T; Varner J; Liu M; Smith EM; Neustadt B; Presta M; Armstrong L
    Cancer Res; 2001 Mar; 61(5):2232-8. PubMed ID: 11280792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of integrin alpha(v)beta3 in vascular biology.
    Byzova TV; Rabbani R; D'Souza SE; Plow EF
    Thromb Haemost; 1998 Nov; 80(5):726-34. PubMed ID: 9843163
    [No Abstract]   [Full Text] [Related]  

  • 14. Function and regulation of the beta 3 integrins in hemostasis and vascular biology.
    Shattil SJ
    Thromb Haemost; 1995 Jul; 74(1):149-55. PubMed ID: 8578448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of alpha(v)beta3 integrin-like receptor and glycosaminoglycans in Candida albicans germ tube adhesion to vitronectin and to a human endothelial cell line.
    Santoni G; Spreghini E; Lucciarini R; Amantini C; Piccoli M
    Microb Pathog; 2001 Oct; 31(4):159-72. PubMed ID: 11562169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eptifibatide and 7E3, but not tirofiban, inhibit alpha(v)beta3 integrin-mediated binding of smooth muscle cells to thrombospondin and prothrombin.
    Scarborough RM
    Circulation; 2002 Feb; 105(6):e46. PubMed ID: 11839641
    [No Abstract]   [Full Text] [Related]  

  • 17. Cross talk between alpha(v)beta3 and alpha4beta1 integrins regulates lymphocyte migration on vascular cell adhesion molecule 1.
    Imhof BA; Weerasinghe D; Brown EJ; Lindberg FP; Hammel P; Piali L; Dessing M; Gisler R
    Eur J Immunol; 1997 Dec; 27(12):3242-52. PubMed ID: 9464812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of thrombin on interactions between beta3-integrins and extracellular matrix in platelets and vascular cells.
    Stouffer GA; Smyth SS
    Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):1971-8. PubMed ID: 12947018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycoprotein Wars and PIECE activists.
    Goldberg S
    J Invasive Cardiol; 2003 Jun; 15(6):324-5. PubMed ID: 12777671
    [No Abstract]   [Full Text] [Related]  

  • 20. Is platelet function as measured by Thrombelastograph monitoring in whole blood affected by platelet inhibitors?
    Bailey LA; Sistino JJ; Uber WE
    J Extra Corpor Technol; 2005 Mar; 37(1):43-7. PubMed ID: 15804156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.